Meropenem Puren

Meropenem, the active ingredient in Meropenem Puren, is a carbapenem antibiotic presented as an injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia and septicemia in hospitalized patients.

GNH USA supplies Meropenem Puren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a carbapenem antibiotic used to treat serious infections caused by susceptible bacteria.

- Complicated intra‑abdominal infections: achieves clinical cure and microbiological eradication. - Complicated urinary tract infections: provides rapid bacterial clearance and symptom resolution. - Nosocomial pneumonia: helps patients recover from hospital‑acquired lung infections. - Septicemia: supports systemic infection control and reduces mortality risk.

Meropenem may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Diarrhea: mild to moderate watery stools. - Nausea: occasional feeling of queasiness. - Rash: transient skin erythema. - Elevated liver enzymes: mild transaminase increase.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with respiratory distress. - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile colitis: severe intestinal infection. - Renal dysfunction: acute kidney injury.

When using Meropenem, clinicians should consider several precautionary measures to ensure safe administration. - Renal function: adjust dose in patients with impaired kidney function. - Hypersensitivity: avoid in individuals with known carbapenem or beta‑lactam allergy. - Pregnancy: use only if potential benefit justifies risk, as safety data are limited. - Concomitant valproic acid: monitor for decreased serum levels. - Superinfection: watch for overgrowth of non‑susceptible organisms. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Valproic acid: may reduce valproate concentrations, risking seizure breakthrough. - Probenecid: can increase meropenem plasma levels, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: concurrent nephrotoxic potential; monitor renal function. - Loop diuretics: may enhance nephrotoxicity; assess kidney parameters. - Anticoagulants (warfarin): possible alteration of INR; check coagulation status.